Cargando…

Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis

BACKGROUND: Hepatitis E virus (HEV) infection is underdiagnosed due to the use of serological assays with low sensitivity. Although most patients with HEV recover completely, HEV infection among patients with pre-existing chronic liver disease and organ-transplant recipients on immunosuppressive the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansrivijit, Panupong, Trongtorsak, Angkawipa, Puthenpura, Max M, Boonpheng, Boonphiphop, Thongprayoon, Charat, Wijarnpreecha, Karn, Choudhury, Avishek, Kaewput, Wisit, Mao, Shennen A, Mao, Michael A, Jadlowiec, Caroline C, Cheungpasitporn, Wisit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006097/
https://www.ncbi.nlm.nih.gov/pubmed/33828397
http://dx.doi.org/10.3748/wjg.v27.i12.1240
_version_ 1783672245029175296
author Hansrivijit, Panupong
Trongtorsak, Angkawipa
Puthenpura, Max M
Boonpheng, Boonphiphop
Thongprayoon, Charat
Wijarnpreecha, Karn
Choudhury, Avishek
Kaewput, Wisit
Mao, Shennen A
Mao, Michael A
Jadlowiec, Caroline C
Cheungpasitporn, Wisit
author_facet Hansrivijit, Panupong
Trongtorsak, Angkawipa
Puthenpura, Max M
Boonpheng, Boonphiphop
Thongprayoon, Charat
Wijarnpreecha, Karn
Choudhury, Avishek
Kaewput, Wisit
Mao, Shennen A
Mao, Michael A
Jadlowiec, Caroline C
Cheungpasitporn, Wisit
author_sort Hansrivijit, Panupong
collection PubMed
description BACKGROUND: Hepatitis E virus (HEV) infection is underdiagnosed due to the use of serological assays with low sensitivity. Although most patients with HEV recover completely, HEV infection among patients with pre-existing chronic liver disease and organ-transplant recipients on immunosuppressive therapy can result in decompensated liver disease and death. AIM: To demonstrate the prevalence of HEV infection in solid organ transplant (SOT) recipients. METHODS: We searched Ovid MEDLINE, EMBASE, and the Cochrane Library for eligible articles through October 2020. The inclusion criteria consisted of adult patients with history of SOT. HEV infection is confirmed by either HEV-immunoglobulin G, HEV-immunoglobulin M, or HEV RNA assay. RESULTS: Of 563 citations, a total of 22 studies (n = 4557) were included in this meta-analysis. The pooled estimated prevalence of HEV infection in SOT patients was 20.2% [95% confidence interval (CI): 14.9-26.8]. The pooled estimated prevalence of HEV infection for each organ transplant was as follows: liver (27.2%; 95%CI: 20.0-35.8), kidney (12.8%; 95%CI: 9.3-17.3), heart (12.8%; 95%CI: 9.3-17.3), and lung (5.6%; 95%CI: 1.6-17.9). Comparison across organ transplants demonstrated statistical significance (Q = 16.721, P = 0.002). The subgroup analyses showed that the prevalence of HEV infection among SOT recipients was significantly higher in middle-income countries compared to high-income countries. The pooled estimated prevalence of de novo HEV infection was 5.1% (95%CI: 2.6-9.6) and the pooled estimated prevalence of acute HEV infection was 4.3% (95%CI: 1.9-9.4). CONCLUSION: HEV infection is common in SOT recipients, particularly in middle-income countries. The prevalence of HEV infection in lung transplant recipients is considerably less common than other organ transplants. More studies examining the clinical impacts of HEV infection in SOT recipients, such as graft failure, rejection, and mortality are warranted.
format Online
Article
Text
id pubmed-8006097
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-80060972021-04-06 Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis Hansrivijit, Panupong Trongtorsak, Angkawipa Puthenpura, Max M Boonpheng, Boonphiphop Thongprayoon, Charat Wijarnpreecha, Karn Choudhury, Avishek Kaewput, Wisit Mao, Shennen A Mao, Michael A Jadlowiec, Caroline C Cheungpasitporn, Wisit World J Gastroenterol Meta-Analysis BACKGROUND: Hepatitis E virus (HEV) infection is underdiagnosed due to the use of serological assays with low sensitivity. Although most patients with HEV recover completely, HEV infection among patients with pre-existing chronic liver disease and organ-transplant recipients on immunosuppressive therapy can result in decompensated liver disease and death. AIM: To demonstrate the prevalence of HEV infection in solid organ transplant (SOT) recipients. METHODS: We searched Ovid MEDLINE, EMBASE, and the Cochrane Library for eligible articles through October 2020. The inclusion criteria consisted of adult patients with history of SOT. HEV infection is confirmed by either HEV-immunoglobulin G, HEV-immunoglobulin M, or HEV RNA assay. RESULTS: Of 563 citations, a total of 22 studies (n = 4557) were included in this meta-analysis. The pooled estimated prevalence of HEV infection in SOT patients was 20.2% [95% confidence interval (CI): 14.9-26.8]. The pooled estimated prevalence of HEV infection for each organ transplant was as follows: liver (27.2%; 95%CI: 20.0-35.8), kidney (12.8%; 95%CI: 9.3-17.3), heart (12.8%; 95%CI: 9.3-17.3), and lung (5.6%; 95%CI: 1.6-17.9). Comparison across organ transplants demonstrated statistical significance (Q = 16.721, P = 0.002). The subgroup analyses showed that the prevalence of HEV infection among SOT recipients was significantly higher in middle-income countries compared to high-income countries. The pooled estimated prevalence of de novo HEV infection was 5.1% (95%CI: 2.6-9.6) and the pooled estimated prevalence of acute HEV infection was 4.3% (95%CI: 1.9-9.4). CONCLUSION: HEV infection is common in SOT recipients, particularly in middle-income countries. The prevalence of HEV infection in lung transplant recipients is considerably less common than other organ transplants. More studies examining the clinical impacts of HEV infection in SOT recipients, such as graft failure, rejection, and mortality are warranted. Baishideng Publishing Group Inc 2021-03-28 2021-03-28 /pmc/articles/PMC8006097/ /pubmed/33828397 http://dx.doi.org/10.3748/wjg.v27.i12.1240 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Meta-Analysis
Hansrivijit, Panupong
Trongtorsak, Angkawipa
Puthenpura, Max M
Boonpheng, Boonphiphop
Thongprayoon, Charat
Wijarnpreecha, Karn
Choudhury, Avishek
Kaewput, Wisit
Mao, Shennen A
Mao, Michael A
Jadlowiec, Caroline C
Cheungpasitporn, Wisit
Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
title Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
title_full Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
title_fullStr Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
title_full_unstemmed Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
title_short Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
title_sort hepatitis e in solid organ transplant recipients: a systematic review and meta-analysis
topic Meta-Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006097/
https://www.ncbi.nlm.nih.gov/pubmed/33828397
http://dx.doi.org/10.3748/wjg.v27.i12.1240
work_keys_str_mv AT hansrivijitpanupong hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT trongtorsakangkawipa hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT puthenpuramaxm hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT boonphengboonphiphop hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT thongprayooncharat hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT wijarnpreechakarn hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT choudhuryavishek hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT kaewputwisit hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT maoshennena hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT maomichaela hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT jadlowieccarolinec hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis
AT cheungpasitpornwisit hepatitiseinsolidorgantransplantrecipientsasystematicreviewandmetaanalysis